For comments, suggestions
Created with Raphaël 2.1.0 17.09.2010 Transformation into patent application 08.12.2010 Preliminary and substantive examination 31.07.2011 Publication of the decision of grant (B1) 31.01.2012 Completion of the opposition filing period 29.02.2012 Issuance of patent (C1) 02.09.2020 Valid until 30.04.2022 Publication of the decision of forfeiture, the term of re-establishment has expired

Patent lapsed


(11)Number of the document4118
(21)Number of the applicationa 2010 0102
(22)Filing date of the application2010.09.02
 Date of filing the request for examination (de fond) 24.03.2011
(71)Name(s) of applicant(s), code of the countryINSTITUTUL DE CHIMIE, MD;
(72)Name(s) of inventor(s), code of the countryMACAEV Fliur, MD; RIBKOVSKAIA Zinaida, MD; POGREBNOI Serghei, MD;
(73)Name(s) of owner(s), code of the countryINSTITUTUL DE CHIMIE AL ACADEMIEI DE STIINTE A MOLDOVEI, MD;
(54)Title of the invention1,3,4-Oxadiazole compounds containing disubstituted thiourea, manifesting antituberculous properties
(67)*Converted applicatiuon and date of conversions 2010 0139 2010.09.17
(13)Kind-of-document code
C1, BOPI 02/2012
B1, BOPI 07/2011
(51)International Patent Classification C07D 271/10 (2006.01); C07D 271/113 (2006.01); C07C 335/08 (2006.01); C07C 335/14 (2006.01); A61K 31/17 (2006.01); A61P 31/06 (2006.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2011.07.31
(47)Date of issuance of patent2012.02.29
 Substantive examiner(s)LEVIŢCHI Svetlana, JOVMIR Tudor
 Payment for maintenance up to the date2020.09.02
 Date of patent termination2020.09.02
 Date of publication of the termination of patent, with the right of restoration2021.04.30
 Date of publication of the termination of patent, without the right of restoration2022.04.30
Up
/inventions/details/a 2010 0102